ASX Announcements 2021 Home » Investors » ASX Announcements » ASX Announcements 2021 InvestorsASX AnnouncementsCorporate GovernanceShare PriceInvestor PresentationsAnnual Reports 2021 16.12.2021 - IDT Australia - Onshore mRNA Manufacturing ATM Outcome and Strategy Update 14.12.2021 - IDT Australia Limited Trading Halt Request 13.12.2021 - IDT Australia Limited Investor Update - mRNA 30.11.2021 - Successful Manufacture of Australia's 1st mRNA COVID-19 Vaccine Candidate 18.11.2021 - Form 3Y and 3Z - Mary Sontrop 16.11.2021 - IDT Australia 2021 AGM Voting Summary 16.11.2021 - IDT Australia 2021 AGM Presentation 21.10.2021 - Jobkeeper payments notice 15.10.2021 - IDT Australia Notice of AGM 2021 15.10.2021 - IDT-Australia-Limited-Director-Retirement.pdf 13.10.2021 - IDT Executes Manufacturing Agreement With Monash 08.10.2021 - Notice received from Regal Funds Management Asia Pte Limited 28.09.2021 - IDT Receives Sterile Licence From TGA 21.09.2021 - Date of Forthcoming AGM and Other Relevant Dates 15.09.2021 - Strategy Update 15.09.2021 - Supp Disclosure Regarding Sterile Readiness Agreement 25.08.2021 - IDT Australia Investor Highlights 2021 25.08.2021 -IDT Australia Annual Report 2021 25.08.2021 - IDT Australia Appendix 4G 30 June 2021 25.08.2021 - IDT Australia Appendix 4E 30 June 2021 23.08.2021 - Media Interest, MIPS’ COVID-19 Vaccine & Sterile Readiness 22.06.2021 - COVID-19 Vaccine Manufacturing discussions with Victorian Government and Monash Institute of Pharmaceutical Sciences 22.06.2021 - IDT Receives First Commercial Shipment of Medicinal Cannabis Flower through a Commercial Partnership with Clever Leaves 19.03.2021 – Covid-19 Vaccine – Feasibility Assessment 23.02.2021-IDT Australia Half Year Report 31 December 2020 23.02.2021-IDT Australia Appendix 4D December 2020 23.02.2021-IDT Australia FY21 Interim Results and Investor Update 23.02.2021-Appendix 2A